Evaluation of Vonoprazan Fumarate Tablets by Rapid Guideline for Drug Evaluation and Selection in Chinese Medical Institutions

XUE Chaojun; DU Yuhan; JIN Huixin; WEI Xin

doi:10.14009/j.issn.1672-2124.2022.10.017

您当前的位置：

首页 >

文章列表页 >

Evaluation of Vonoprazan Fumarate Tablets by Rapid Guideline for Drug Evaluation and Selection in Chinese Medical Institutions

更新时间：2023-04-16

- Evaluation of Vonoprazan Fumarate Tablets by Rapid Guideline for Drug Evaluation and Selection in Chinese Medical Institutions
- Vol. 22, Issue 10, Pages: 1228-1232(2022)
- 作者机构：
  
  1. 河北省人民医院药学部
  2. 河北省人民医院神经内五科
- 作者简介：
- 基金信息：
- DOI：10.14009/j.issn.1672-2124.2022.10.017
  CLC： R95
- Published：2022，
扫描看全文
XUE Chaojun, DU Yuhan, JIN Huixin, et al. Evaluation of Vonoprazan Fumarate Tablets by Rapid Guideline for Drug Evaluation and Selection in Chinese Medical Institutions. [J]. 22(10):1228-1232(2022)
DOI：

XUE Chaojun, DU Yuhan, JIN Huixin, et al. Evaluation of Vonoprazan Fumarate Tablets by Rapid Guideline for Drug Evaluation and Selection in Chinese Medical Institutions. [J]. 22(10):1228-1232(2022) DOI： 10.14009/j.issn.1672-2124.2022.10.017.

摘要

目的：对新型钾离子竞争性酸阻滞剂富马酸伏诺拉生片进行药品评价，为医疗机构遴选该药品提供参考。方法：使用《中国医疗机构药品评价与遴选快速指南》(以下简称《快速指南》)的评价维度、评价细则及评价方法，对富马酸伏诺拉生片进行药品评价。结果：基于《快速指南》

富马酸伏诺拉生片的总评分为73.8分；其中，药学特性18.8分，有效性18分，安全性9分，经济性14分，其他指标14分。结论：富马酸伏诺拉生片的推荐意见为强推荐。《快速指南》能帮助医疗机构快速地评价与遴选药品，有在医疗机构推广的潜力和价值。

Abstract

OBJECTIVE: To perform drug evaluation on the new potassium-competitive acid blocker Vonoprazan fumarate tablets

so as to provide reference for medical institutions to select the drug. METHODS: Evaluation dimensions

rules and methods of Rapid Guideline for Drug Evaluation and Selection in Chinese Medical Institutions（hereinafter referred to as “Rapid Guideline”） were used to evaluate the Vonoprazan fumarate tablets. RESULTS: Based on Rapid Guideline

the total score of Vonoprazan fumarate tablets was 73.8. Among them

18.8 points for pharmacological properties

18 points for effectiveness

9 points for safety

14 points for economy and 14 points for other indicators. CONCLUSIONS: The recommendation for Vonoprazan fumarate tablets is strong. Rapid Guideline can help medical institutions to evaluate and select drugs quickly

and has the potential and value to be promoted in medical institutions.

关键词

新型钾离子竞争性酸阻滞剂伏诺拉生药品评价药品遴选中国医疗机构药品评价与遴选快速指南

Keywords

Potassium-competitive acid blockerVonoprazanDrug evaluationDrug selectionRapid Guideline for Drug Evaluation and Selection in Chinese Medical Institutions

references

查看原文

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Drug Selection Guideline for Medical Institutions: Recommendations External Review

Research on Method of Recognizing Rare Disease Drugs in Drug Clinical Necessity Assessment of Drug Selection in Medical Institutions

Research Status and Reflection of Methods and Tools for Drug Selection and Evaluation in Medical Institutions from China

Related Author

LI Zhengxiang

DUAN Rong

YU Jie

DUAN Rong

WU Jiayao

ZHONG Weilong

LI Zhengxiang

Related Institution

Dept.of Pharmacy, Tianjin Medical University General Hospital

Dept.of Pharmacy, General Hospital of Tianjin Medical University

Dept.of Gastroenterology, General Hospital of Tianjin Medical University

⁰